Trials

University Hospitals Birmingham NHS Foundation Trust is a regional and national centre for specialist clinical services.

It is home to some of the country’s leading clinical research institutions, and is dedicated to developing and implementing groundbreaking treatments, technologies and techniques.

  • Dietary management clinical status and outcome of patients with Citrin deficiency in the UK

    View Trial
  • A Comparison of the Natural History of Patients with and without Familial Chylomicronaemia Syndrome (FCS).

    View Trial
  • FOCUS4

    FOCUS4 – Molecular selection of therapy in colorectal cancer: a molecularly stratified randomised controlled trials programme

    View Trial
  • EORTC-STBSG-1647

    EORTC-STBSG Retrospective evaluation of neoadjuvant/adjuvant treatment in angiosarcoma

    View Trial
  • Blood phenylalanine control of patients with Phenylketonuria in the UK

    View Trial
  • CHECKMATE 227

    An OpenLabel Randomized Phase 3 Trial of Nivolumab or Nivolumab plus Ipilimumab versus platinum doublet chemotherapy in Subjects with ChemotherapyNaïve Stage IV or Recurrent NonSmall Cell Lung Cancer (NSCLC)

    View Trial
  • Characterising the immune profile and microenvironment of solid tumours and investigating how these features correlate with clinical prognosis and response to treatment

    View Trial
  • Investigating the immune response to haematological malignancies with a view to novel therapies

    View Trial
  • SOLAR: A Phase 2 Randomized Open-label Parallel-group Active Comparator Multi-center Study to Investigate the Efficacy and Safety of Cobomarsen (MRG-106) in Subjects with Cutaneous T-Cell Lymphoma (CTCL) Mycosis Fungoides (MF) Subtype

    View Trial
  • PARCT

    Phase II trial of atezolizumab (anti-PD-L1) in the treatment of stage IIb-IV mycosis fungoides/sezary syndrome patients relapsed/refractory after a previous systemic treatment (PARCT)

    View Trial